16 results
8-K
EX-1.1
SONN
Sonnet BioTherapeutics Holdings Inc
13 Feb 23
Sonnet BioTherapeutics Announces Pricing of $15.0 Million Underwritten Public Offering
6:05am
8-K
EX-1.1
i2vbs8wclngx00tuc040
15 Aug 22
Sonnet BioTherapeutics Provides Fiscal Year 2022 Third Quarter Business and Earnings Update
4:32pm
SC 13G/A
EX-1
3rzm7
16 Feb 21
Sonnet BioTherapeutics / Altium Capital Management ownership change
7:32am
8-K
EX-1.1
lefldkvyoa7
5 Feb 21
Entry into a Material Definitive Agreement
5:19pm
SC 13D
EX-1
8yflsd r716h8c
2 Dec 19
Chanticleer Holdings, Inc.
12:38pm
8-K
EX-1.1
nkngi9n00log2af0cq7i
27 Jun 12
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next